Panacea Index Logo

Command Palette

Search for a command to run...

The effect of gluten in adolescents and young adults with gastrointestinal symptoms: a blinded randomised cross-over trial.

Alimentary pharmacology & therapeutics
May 1, 2022
Caecilie Crawley et al. (9 authors)
Clinical Trial, Phase IIJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether gluten induces gastrointestinal or mental health symptoms in adolescents following a gluten-free diet.

Results Summary

The study found no significant difference in gastrointestinal or mental health symptoms between gluten and placebo groups, suggesting gluten did not induce symptoms in this population.

Population

Adolescents (median age 20.3, predominantly female) from a population-based cohort with at least four gastrointestinal symptoms.

Effective Dosage

Two granola bars containing 10 g of gluten daily for 7 days.

Duration

2-week run-in phase (gluten-free), followed by 7-day gluten/placebo periods with a 7-day washout.

Interactions

None mentioned

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
gluten-free diet
decrease
gastrointestinal symptoms
adolescents from a population-based cohort with at least four different gastrointestinal symptoms
-
improved
#1
gluten
no change
gastrointestinal symptoms
adolescents recruited from a population-based cohort
difference in the average VAS was -0.01 (95% confidence interval -2.07 to 2.05)
did not induce
#2
gluten
no change
mental health symptoms
adolescents recruited from a population-based cohort
-
did not induce a difference
#3
Abstract

BACKGROUND: The popularity of the gluten-free diet and sales of gluten-free products have increased immensely. AIMS: To investigate whether gluten induces gastrointestinal symptoms, measured by self-reported questionnaires, as well as mental health symptoms in adolescents from a population-based cohort. METHODS: The eligible participants (n = 273) were recruited from a population-based cohort of 1266 adolescents and had at least four different gastrointestinal symptoms. Phase one (n = 54) was a run-in phase where the participants lived gluten-free for 2 weeks. If they improved they continued to phase 2 (n = 33), a blinded randomised cross-over trial. Participants were blindly randomised either to start with 7 days of gluten, eating two granola bars containing 10 g of gluten or to 7 days on placebo, eating two granola bars without gluten, followed by the reverse and separated by a 7-day washout period. The effects of the intervention on gastrointestinal symptoms and mental health symptoms were assessed. RESULTS: In total, 54/273 participants entered the run-in phase and 35 were eligible for randomization. A total of 33 were randomised and 32 completed the trial. The median age was 20.3 (IQR 19.2-20.9) and 32/33 participants were females. Compared with a placebo, gluten did not induce gastrointestinal symptoms. The difference in the average VAS was -0.01 (95% confidence interval -2.07 to 2.05). Nor did we find a difference in the outcomes measuring mental health. CONCLUSION: Compared with placebo, adding gluten to the diet did not induce gastrointestinal symptoms or worsened mental health in adolescents recruited from a population-based cohort. The trial registration number is NCT04639921.

Medical Subject Headings (MeSH)
AdolescentAdultCeliac DiseaseCross-Over StudiesDiet, Gluten-FreeDouble-Blind MethodFemaleGastrointestinal DiseasesGlutensHumansMaleYoung Adult
Study Links
Quality Scores
Safety90
Efficacy70/10
Quality85/10
Citation Metrics
Total Citations15
Citations/Year5.0
Relative Citation Ratio2.46
NIH Percentile80.3%
Research Impact Scores
APT Score0.75
Weight Score2.82
Normalized Score0.81
Related Supplements